IL-22 controls iron-dependent nutritional immunity against systemic bacterial infections

Kei Sakamoto, Yungi Kim, Hideki Hara, Nobuhiko Kamada, Gustavo Caballero-Flores, Emanuela Tolosano, Miguel P. Soares, José L. Puente, Naohiro Inohara, Gabriel Núñez

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Host immunity limits iron availability to pathogenic bacteria, but whether immunity limits pathogenic bacteria from accessing host heme, the major source of iron in the body, remains unclear. Using Citrobacter rodentium (a mouse enteric pathogen) and Escherichia coli (a major cause of sepsis in humans) as models, we find that interleukin-22 (IL-22), a cytokine best known for its ability to promote epithelial barrier function, also suppresses the systemic growth of bacteria by limiting iron availability to the pathogen. To understand the mechanistic basis of IL-22–dependent iron retention in the host, using an unbiased proteomic approach, we have identified that IL-22 induces the production of the plasma hemoglobin scavenger haptoglobin and the heme scavenger hemopexin. Moreover, the antimicrobial effect of IL-22 depends on the induction of hemopexin expression, whereas haptoglobin was dispensable. Impaired pathogen clearance in infected Il22−/− mice was restored by hemopexin administration, and hemopexin-deficient mice had increased pathogen loads after infection. These studies reveal a previously unrecognized host defense mechanism regulated by IL-22 that relies on the induction of hemopexin to limit heme availability to bacteria, leading to suppression of bacterial growth during systemic infections.

Original languageEnglish
Article numbereaai8371
JournalScience Immunology
Volume2
Issue number8
DOIs
Publication statusPublished - 2017 Jan 1
Externally publishedYes

Fingerprint

Hemopexin
Bacterial Infections
Immunity
Iron
Heme
Bacteria
Haptoglobins
Citrobacter rodentium
Growth
Infection
Proteomics
Sepsis
Hemoglobins
interleukin-22
Cytokines
Escherichia coli

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sakamoto, K., Kim, Y., Hara, H., Kamada, N., Caballero-Flores, G., Tolosano, E., ... Núñez, G. (2017). IL-22 controls iron-dependent nutritional immunity against systemic bacterial infections. Science Immunology, 2(8), [eaai8371]. https://doi.org/10.1126/sciimmunol.aai8371

IL-22 controls iron-dependent nutritional immunity against systemic bacterial infections. / Sakamoto, Kei; Kim, Yungi; Hara, Hideki; Kamada, Nobuhiko; Caballero-Flores, Gustavo; Tolosano, Emanuela; Soares, Miguel P.; Puente, José L.; Inohara, Naohiro; Núñez, Gabriel.

In: Science Immunology, Vol. 2, No. 8, eaai8371, 01.01.2017.

Research output: Contribution to journalArticle

Sakamoto, K, Kim, Y, Hara, H, Kamada, N, Caballero-Flores, G, Tolosano, E, Soares, MP, Puente, JL, Inohara, N & Núñez, G 2017, 'IL-22 controls iron-dependent nutritional immunity against systemic bacterial infections', Science Immunology, vol. 2, no. 8, eaai8371. https://doi.org/10.1126/sciimmunol.aai8371
Sakamoto, Kei ; Kim, Yungi ; Hara, Hideki ; Kamada, Nobuhiko ; Caballero-Flores, Gustavo ; Tolosano, Emanuela ; Soares, Miguel P. ; Puente, José L. ; Inohara, Naohiro ; Núñez, Gabriel. / IL-22 controls iron-dependent nutritional immunity against systemic bacterial infections. In: Science Immunology. 2017 ; Vol. 2, No. 8.
@article{8e282e79e6fc4c2e958ba96bc0b99a22,
title = "IL-22 controls iron-dependent nutritional immunity against systemic bacterial infections",
abstract = "Host immunity limits iron availability to pathogenic bacteria, but whether immunity limits pathogenic bacteria from accessing host heme, the major source of iron in the body, remains unclear. Using Citrobacter rodentium (a mouse enteric pathogen) and Escherichia coli (a major cause of sepsis in humans) as models, we find that interleukin-22 (IL-22), a cytokine best known for its ability to promote epithelial barrier function, also suppresses the systemic growth of bacteria by limiting iron availability to the pathogen. To understand the mechanistic basis of IL-22–dependent iron retention in the host, using an unbiased proteomic approach, we have identified that IL-22 induces the production of the plasma hemoglobin scavenger haptoglobin and the heme scavenger hemopexin. Moreover, the antimicrobial effect of IL-22 depends on the induction of hemopexin expression, whereas haptoglobin was dispensable. Impaired pathogen clearance in infected Il22−/− mice was restored by hemopexin administration, and hemopexin-deficient mice had increased pathogen loads after infection. These studies reveal a previously unrecognized host defense mechanism regulated by IL-22 that relies on the induction of hemopexin to limit heme availability to bacteria, leading to suppression of bacterial growth during systemic infections.",
author = "Kei Sakamoto and Yungi Kim and Hideki Hara and Nobuhiko Kamada and Gustavo Caballero-Flores and Emanuela Tolosano and Soares, {Miguel P.} and Puente, {Jos{\'e} L.} and Naohiro Inohara and Gabriel N{\'u}{\~n}ez",
year = "2017",
month = "1",
day = "1",
doi = "10.1126/sciimmunol.aai8371",
language = "English",
volume = "2",
journal = "Science immunology",
issn = "2470-9468",
publisher = "American Association for the Advancement of Science",
number = "8",

}

TY - JOUR

T1 - IL-22 controls iron-dependent nutritional immunity against systemic bacterial infections

AU - Sakamoto, Kei

AU - Kim, Yungi

AU - Hara, Hideki

AU - Kamada, Nobuhiko

AU - Caballero-Flores, Gustavo

AU - Tolosano, Emanuela

AU - Soares, Miguel P.

AU - Puente, José L.

AU - Inohara, Naohiro

AU - Núñez, Gabriel

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Host immunity limits iron availability to pathogenic bacteria, but whether immunity limits pathogenic bacteria from accessing host heme, the major source of iron in the body, remains unclear. Using Citrobacter rodentium (a mouse enteric pathogen) and Escherichia coli (a major cause of sepsis in humans) as models, we find that interleukin-22 (IL-22), a cytokine best known for its ability to promote epithelial barrier function, also suppresses the systemic growth of bacteria by limiting iron availability to the pathogen. To understand the mechanistic basis of IL-22–dependent iron retention in the host, using an unbiased proteomic approach, we have identified that IL-22 induces the production of the plasma hemoglobin scavenger haptoglobin and the heme scavenger hemopexin. Moreover, the antimicrobial effect of IL-22 depends on the induction of hemopexin expression, whereas haptoglobin was dispensable. Impaired pathogen clearance in infected Il22−/− mice was restored by hemopexin administration, and hemopexin-deficient mice had increased pathogen loads after infection. These studies reveal a previously unrecognized host defense mechanism regulated by IL-22 that relies on the induction of hemopexin to limit heme availability to bacteria, leading to suppression of bacterial growth during systemic infections.

AB - Host immunity limits iron availability to pathogenic bacteria, but whether immunity limits pathogenic bacteria from accessing host heme, the major source of iron in the body, remains unclear. Using Citrobacter rodentium (a mouse enteric pathogen) and Escherichia coli (a major cause of sepsis in humans) as models, we find that interleukin-22 (IL-22), a cytokine best known for its ability to promote epithelial barrier function, also suppresses the systemic growth of bacteria by limiting iron availability to the pathogen. To understand the mechanistic basis of IL-22–dependent iron retention in the host, using an unbiased proteomic approach, we have identified that IL-22 induces the production of the plasma hemoglobin scavenger haptoglobin and the heme scavenger hemopexin. Moreover, the antimicrobial effect of IL-22 depends on the induction of hemopexin expression, whereas haptoglobin was dispensable. Impaired pathogen clearance in infected Il22−/− mice was restored by hemopexin administration, and hemopexin-deficient mice had increased pathogen loads after infection. These studies reveal a previously unrecognized host defense mechanism regulated by IL-22 that relies on the induction of hemopexin to limit heme availability to bacteria, leading to suppression of bacterial growth during systemic infections.

UR - http://www.scopus.com/inward/record.url?scp=85027585989&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027585989&partnerID=8YFLogxK

U2 - 10.1126/sciimmunol.aai8371

DO - 10.1126/sciimmunol.aai8371

M3 - Article

AN - SCOPUS:85027585989

VL - 2

JO - Science immunology

JF - Science immunology

SN - 2470-9468

IS - 8

M1 - eaai8371

ER -